Bio-Rad Laboratories EBIT Margin 2010-2025 | BIO

Bio-Rad Laboratories ebit margin for the quarter ending March 31, 2025 was 9.72%.

  • Bio-Rad Laboratories average ebit margin for 2024 was 11.89%, a 11.2% decline from 2023.
  • Bio-Rad Laboratories average ebit margin for 2023 was 13.39%, a 25.86% decline from 2022.
  • Bio-Rad Laboratories average ebit margin for 2022 was 18.06%, a 1.75% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Bio-Rad Laboratories EBIT Margin 2010-2025 | BIO

  • Bio-Rad Laboratories average ebit margin for 2024 was 11.89%, a 11.2% decline from 2023.
  • Bio-Rad Laboratories average ebit margin for 2023 was 13.39%, a 25.86% decline from 2022.
  • Bio-Rad Laboratories average ebit margin for 2022 was 18.06%, a 1.75% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$222.7B
Boston Scientific (BSX)$157.5B
Stryker (SYK)$152.9B
EssilorLuxottica (ESLOY)$140.2B
Medtronic (MDT)$118.6B
Lonza Group Ag (LZAGY)$50.6B
Haleon (HLN)$44.1B
ResMed (RMD)$40.7B
GE HealthCare Technologies (GEHC)$35.6B
Agilent Technologies (A)$34B
Koninklijke Philips (PHG)$27B
Terumo (TRUMY)$25.7B
Insulet (PODD)$20.5B
Zimmer Biomet Holdings (ZBH)$18.8B
Baxter (BAX)$14.8B
Smith & Nephew SNATS (SNN)$13.8B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.7B
Haemonetics (HAE)$3.6B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
ICU Medical (ICUI)$3.1B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.7B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.3B